Prosus Stock (OTC:PROSY), Trade Ideas

Prosus NV is a consumer internet group operating across a variety of platforms and geographies. The group's businesses operate in China, India, Russia, Central and Eastern Europe, North America, Latin America, Southeast Asia, the Middle East, and Africa. The group's businesses and investments are organized around the following segments: Ecommerce, which comprises its interests in Classifieds, Payments, and Fintech, Food Delivery, Etail, Travel, and other Ecommerce, Social and Internet Platforms, which comprises its interests in Tencent and Mail.ru Group and Corporate which relates to group-level corporate services and treasury function.

Government

Large Cap

News

Penny Stocks

Health Care

Markets

Movers

Tech

Media

Trading Ideas

General

BABA

CARR

DIDI GLOBAL INC S/ADR by DiDi Global Inc.

DIDIY

European Aeronautic Defence And Space Unsponsored

EADSY

KSHTY

KUASF

NATI

NVDA

PROSF

PROSY

SFTBF

SFTBY

TCEHY

TSLA

Elon Musk and BBC Reporter Clash In Twitter Spaces, Get Paid To Hack OpenAI, US States Stockpile Alternative Abortion Pill: Today&#39;s Top Stories

NAPRF

NPSNY

Tencent Suffers Heavy Losses On News Of Largest Shareholder&#39;s Stock Sale

JTKWY

Just Eat Takeaway.com Shares Soar On $1.8B iFood Stake Sale

Prosus NV

Citigroup analyst Paul Lejuez maintains Costco Wholesale (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>) with a Neutral and raises the price target from $630 to $710.

Price Target

Analyst Ratings

COST

Citigroup Maintains Neutral on Costco Wholesale, Raises Price Target to $710

Wedbush analyst David Nierengarten reiterates Beam Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BEAM#NASDAQ">BEAM</a>) with a Outperform and maintains $57 price target.

Reiteration

BEAM

Wedbush Reiterates Outperform on Beam Therapeutics, Maintains $57 Price Target

Archer-Daniels-Midland Company&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ADM#NYSE">ADM</a>) shares are trading lower today. On Monday, the company disclosed that Chief Financial Officer (CFO) Vikram Luthar plans to resign from the post effective September 30,&nbsp;<a target="_blank" href="https://d18rn0p25nwr6d.cloudfront.net/CIK-0000007084/d6b81032-8336-466a-8f61-70d854048ee3.pdf" rel="noreferrer noopener">2024</a>.
The company said Luthar will receive an annual cash performance incentive&nbsp;award of $743,419 for 2023 and shares earned in 2021 related to the company&#8217;s performance.&nbsp;
Luthar will remain at the company as a non-executive employee until his resignation date to provide transitional support as the company searches for a new CFO.
Read:&nbsp;<a target="_blank" href="https://www.benzinga.com/news/24/01/36818585/leaked-memo-reveals-adm-delays-executive-bonuses-as-accounting-probe-unfolds-report" rel="noreferrer noopener">ADM Executive Bonuses Delayed Amidst Accounting Probe, Leaked Memo Reveals: Report</a>
Luthar is the highest-level executive to leave the firm since the company announced accounting issues within its Nutrition division, as per Reuters.
In January 2024, Archer-Daniels-Midland placed Vikram Luthar on leave due to an investigation studying accounting practices and procedures related to its nutrition segment and appointed Ismael Roig&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/equities/24/01/36719166/why-food-processing-company-archer-daniels-midland-shares-are-sinking-today" rel="noreferrer noopener">as its interim CFO</a>.&nbsp;
&#8220;The decision to move forward in this direction was made&nbsp;after careful consideration of the future of our company and how to best position ADM for success,&#8221; CEO Juan Luciano said in an internal memo seen by Reuters.
Last month, Archer-Daniels-Midland reported a fourth-quarter FY23 revenue of $22.98 billion, which missed the consensus estimate of $23.64 billion, and adjusted EPS of $1.36 missed&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/equities/24/03/37628022/whats-going-on-with-archer-daniels-midland-shares-today" rel="noreferrer noopener">the consensus estimate of $1.43</a>.
Related:&nbsp;<a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/01/36723510/archer-daniels-midlands-financial-figures-are-too-high-analyst-downgrades-stock" rel="noreferrer noopener">Archer-Daniels-Midland&#8217;s&nbsp;Financial Figures &#8216;Are Too High,&#8217; Analyst Downgrades Stock</a>
&nbsp;Investors can gain exposure to the stock via&nbsp;First Trust Nasdaq Food &amp; Beverage ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTXG#NASDAQ">FTXG</a>) and&nbsp;First Trust Indxx Global Natural Resources Income ETF&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTRI#NASDAQ">FTRI</a>).
Price Action: ADM shares are trading lower by 1.31% at $61.68 at the last check Tuesday.
Photo via Shutterstock

Equities

Management

FTRI

FTXG

What's Going On With Food Processing Company Archer-Daniels-Midland Shares Today?

Given the recent talk about higher interest rates being a headwind for real estate investment trusts (REITs), investors might anticipate that first-quarter operating results could be lackluster or subpar.
However, many initial REIT earnings reports are much better than expected, with several REITs beating the analyst estimates on funds from operations (FFO) or adjusted funds from operations (AFFO). Occupancy levels are still high and full-year 2024 FFO guidance looks sound.&nbsp;
Take a look at three REITs that just declared earnings and are showing up the analyst consensus estimates.&nbsp;
Alexandria Real Estate Equities Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARE#NYSE">ARE</a>) is a Pasadena, California-based REIT with a portfolio of 800 tenants devoted to life science, agtech and advanced technology companies in what its website calls "top innovation clusters." These areas include cities like Boston, New York City, Seattle and San Francisco. Mega campuses make up 75% of its annual rental revenue. Alexandria is a member of the S&amp;P 500.
Don't Miss:
<ul>
<li>Investing in real estate just got a whole lot simpler. This <a href="https://www.benzinga.com/go/bezos-landlord">Jeff Bezos-backed startup will allow you to become a landlord</a> in just 10 minutes, and you only need $100.</li>
</ul>
Of Alexandria's leases, 94% are triple-net and 96% contain annual rent escalations. The weighted average remaining term (WALT) of its top 20 tenants is 9.7 years and for all tenants, the WALT is 7.5 years&nbsp; The tenant quality is strictly higher-grade with many of its tenants publicly traded on Wall Street. Moderna Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) and Eli Lilly and Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) are two of its largest tenants. The total occupancy rate as of the first quarter of 2024 was 94.6%.
Alexandria has reported positive news this month.&nbsp; On April 1, it announced an early renewal with insitro on a six-year lease extension through Aug. 31, 2034, in the San Francisco area. Insitro is a machine learning-powered drug discovery and development company.
On April 2, Alexandria announced it's been named one of Newsweek magazine's most trustworthy companies in America for the second consecutive year. Alexandria is first among the three S&amp;P 500 REITs recognized in the real estate and housing category.
On April 22, Alexandria declared its first-quarter operating results. AFFO of $2.35 per share beat the consensus estimate of $2.33 per share and was better than AFFO of $2.19 per share in the first quarter of 2023. Revenue of $769.1 million bested the Street estimate of $762.903 million and was substantially improved from first-quarter 2023 revenue of $700.795 million.
Trending
<ul>
<li>Want to Create a Passive Income Stream? <a href="https://www.benzinga.com/go/grow-wealth-passively">These High-Yield Real Estate Notes Might Be Your Holy Grail</a></li>
</ul>
Alexandria gave investors a hint that its first-quarter earnings would be strong when it increased the dividend by 5% in early March to $1.27 per share or $5.02 per share annually. The dividend yield is presently 4.39%.
Equity LifeStyle Properties Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELS#NYSE">ELS</a>) is a Chicago-based residential REIT that owns and operates manufactured home communities, RV resorts, marinas and campgrounds in North America. Equity LifeStyles owns 450 communities across 35 states and British Columbia. It was founded in 1992 and had its initial public offering (IPO) in 1993.
On April 22, Equity LifeStyle reported its first-quarter operating results. FFO of $0.78 per share was above estimates for $0.77 and topped first-quarter 2023 FFO of $0.74 per share. Revenue of $386.6 million missed the consensus estimate of $389.49 million but solidly trounced the $370 million revenue it reported in the first quarter of 2023.
The forward guidance announced simultaneously with the operating results was even more positive. Equity LifeStyle sees full-year FFO between $1.83-$1.93 per share, well above the consensus estimate of $1.74 per share.
With single-family homes so expensive, manufactured homes remain an alternative for people who would love to buy a home but have a limited budget or down payment funds.
Alpine Income Property Trust Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINE#NYSE">PINE</a>) is a Daytona Beach, Florida-based retail REIT that owns and operates 138 high-quality net-leased properties of 3.8 million square feet across 35 states. Sixty-five percent of its tenants are investment-grade companies such as Lowe's Cos. Inc., Dollar Tree Inc., Walgreens, Walmart Inc., Advanced Auto Parts and Dick's Sporting Goods. As of March 30, Alpine Income Property Trust had an occupancy rate of 99%.
On April 18, Alpine Income reported its first-quarter 2024 operating results. FFO of $0.41 per share topped the Street's view of $0.38 per share and its first-quarter 2023 FFO of $0.36 per share. Revenue of $12.47 million was ahead of analysts' estimates of $11.66 million and was 116% above revenue of $11.17 million in the first quarter of 2023. Alpine Income Property Trust maintained its full-year 2024 AFFO guidance from $1.53-$1.58 per share, slightly above the consensus estimate of $1.54 per share.&nbsp;
On April 19, Jones Trading analyst Jason Weaver maintained Alpine Income Property Trust with a Buy but lowered the price target from $19 to $18. On the same day, Stifel analyst Nathan Jones maintained a Buy on Alpine Income Property Trust but lowered the price target from $19 to $18.75.
&nbsp;&nbsp;Read Next:
<ul>
<li>Want To Grow Your Wealth Passively? Unlock Real Wealth with <a href="https://www.benzinga.com/money/cityfunds-yield">Cityfunds&#8217; Exclusive 8% Yield Fund</a>.</li>
</ul>

REIT

Real Estate

MRNA

PINE

REITs Q1 Earnings Begin On Solid Note

<h3>Gainers</h3>
<ul>
<li>Cazoo Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CZOO#NYSE">CZOO</a>) shares increased by 83.0% to $9.13 during Tuesday's regular session. The market value of their outstanding shares is at $44.6 million. </li>
<li>Volcon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VLCN#NASDAQ">VLCN</a>) shares moved upwards by 20.24% to $0.28. The company's market cap stands at $5.2 million. </li>
<li>Hibbett (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HIBB#NASDAQ">HIBB</a>) stock rose 18.89% to $86.19. The company's market cap stands at $1.0 billion. </li>
<li>Kidpik (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIK#NASDAQ">PIK</a>) shares increased by 17.11% to $3.92. The company's market cap stands at $7.6 million. </li>
<li>17 Education &amp; Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YQ#NASDAQ">YQ</a>) shares rose 16.36% to $2.48. The company's market cap stands at $24.1 million. </li>
<li>Groupon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRPN#NASDAQ">GRPN</a>) stock moved upwards by 14.92% to $11.01. The market value of their outstanding shares is at $429.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>LKQ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LKQ#NASDAQ">LKQ</a>) stock declined by 14.3% to $41.93 during Tuesday's regular session. The company's market cap stands at $11.1 billion. The company's, Q1 earnings came out today. </li>
<li>Mynd.ai (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/MYND#AMEX">MYND</a>) shares declined by 9.1% to $2.8. The company's market cap stands at $127.8 million. </li>
<li>Secoo Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SECO#NASDAQ">SECO</a>) shares declined by 9.01% to $0.39. The market value of their outstanding shares is at $2.7 million. </li>
<li>Singing Machine Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MICS#NASDAQ">MICS</a>) stock decreased by 7.97% to $0.81. The market value of their outstanding shares is at $5.1 million. </li>
<li>Selina Hospitality (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNA#NASDAQ">SLNA</a>) stock decreased by 7.08% to $0.06. The market value of their outstanding shares is at $16.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CZOO

GRPN

HIBB

MICS

MYND

SECO

SLNA

VLCN

11 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>VolitionRX (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VNRX#AMEX">VNRX</a>) shares rose 33.6% to $0.8 during Tuesday's regular session. The market value of their outstanding shares is at $65.7 million. </li>
<li>Palisade Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PALI#NASDAQ">PALI</a>) stock increased by 29.81% to $6.4. The company's market cap stands at $5.4 million. </li>
<li>Kintara Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTRA#NASDAQ">KTRA</a>) shares increased by 24.67% to $0.14. The market value of their outstanding shares is at $5.5 million. </li>
<li>Protagenic Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTIX#NASDAQ">PTIX</a>) shares increased by 23.88% to $1.55. The company's market cap stands at $6.8 million. </li>
<li>BIMI Intl Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIMI#NASDAQ">BIMI</a>) stock moved upwards by 23.21% to $1.38. The market value of their outstanding shares is at $19.3 million. </li>
<li>NKGen Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKGN#NASDAQ">NKGN</a>) shares moved upwards by 20.4% to $1.77. The company's market cap stands at $40.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Abeona Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABEO#NASDAQ">ABEO</a>) shares decreased by 52.3% to $3.51 during Tuesday's regular session. The company's market cap stands at $96.0 million. </li>
<li>Rezolute (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RZLT#NASDAQ">RZLT</a>) stock decreased by 16.97% to $2.94. The market value of their outstanding shares is at $117.9 million. </li>
<li>Jaguar Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAGX#NASDAQ">JAGX</a>) stock decreased by 13.57% to $0.16. The company's market cap stands at $44.6 million. </li>
<li>Adlai Nortye (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANL#NASDAQ">ANL</a>) stock declined by 13.25% to $12.51. The market value of their outstanding shares is at $461.6 million. </li>
<li>Sunshine Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBFM#NASDAQ">SBFM</a>) shares decreased by 12.74% to $1.26. The market value of their outstanding shares is at $1.2 million. </li>
<li>Portage Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRTG#NASDAQ">PRTG</a>) stock fell 12.49% to $0.26. The company's market cap stands at $5.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ABEO

BIMI

JAGX

Kintara Therapeutics, Inc. - Common Stock

KTRA

NKGN

PALI

PRTG

PTIX

RZLT

SBFM

VNRX

12 Health Care Stocks Moving In Tuesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Shimmick (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHIM#NASDAQ">SHIM</a>) stock rose 31.1% to $2.95 during Tuesday's regular session. The company's market cap stands at $75.4 million. </li>
<li>Pineapple Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGY#NASDAQ">PEGY</a>) stock moved upwards by 25.87% to $0.06. The company's market cap stands at $3.6 million. </li>
<li>SolarMax Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMXT#NASDAQ">SMXT</a>) shares moved upwards by 21.06% to $9.69. The company's market cap stands at $438.2 million. </li>
<li>SES AI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SES#NYSE">SES</a>) shares rose 18.69% to $1.36. The company's market cap stands at $484.5 million. </li>
<li>Virgin Galactic Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPCE#NYSE">SPCE</a>) shares moved upwards by 18.36% to $0.89. The company's market cap stands at $356.0 million. </li>
<li>KULR Tech Gr (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/KULR#AMEX">KULR</a>) shares moved upwards by 17.69% to $0.53. The market value of their outstanding shares is at $90.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Greenwave Tech Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GWAV#NASDAQ">GWAV</a>) stock fell 44.0% to $0.07 during Tuesday's regular session. The market value of their outstanding shares is at $3.1 million. </li>
<li>Lichen China (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LICN#NASDAQ">LICN</a>) shares decreased by 40.39% to $0.58. The company's market cap stands at $15.8 million. </li>
<li>Caravelle Intl Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CACO#NASDAQ">CACO</a>) shares fell 28.36% to $0.71. The company's market cap stands at $37.4 million. </li>
<li>JetBlue Airways (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBLU#NASDAQ">JBLU</a>) shares decreased by 15.72% to $6.33. The market value of their outstanding shares is at $2.1 billion. As per the news, the Q1 earnings report came out today. </li>
<li>Zoomcar Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZCAR#NASDAQ">ZCAR</a>) shares fell 12.47% to $0.36. The company's market cap stands at $23.4 million. </li>
<li>CDT Environmental (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDTG#NASDAQ">CDTG</a>) shares decreased by 11.64% to $3.57. The market value of their outstanding shares is at $38.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CACO

CDTG

GWAV

JBLU

KULR

LICN

PEGY

SHIM

SMXT

SPCE

ZCAR

12 Industrials Stocks Moving In Tuesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Cyngn (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYN#NASDAQ">CYN</a>) stock rose 58.2% to $0.19 during Tuesday's regular session. The market value of their outstanding shares is at $17.0 million. </li>
<li>MMTEC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTC#NASDAQ">MTC</a>) stock rose 43.26% to $2.23. The market value of their outstanding shares is at $445.0 million. </li>
<li>NextTrip (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTRP#NASDAQ">NTRP</a>) stock moved upwards by 35.14% to $3.96. The market value of their outstanding shares is at $5.3 million. </li>
<li>BIT Mining (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTCM#NYSE">BTCM</a>) shares rose 20.0% to $3.24. The market value of their outstanding shares is at $36.0 million. </li>
<li>Hitek Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HKIT#NASDAQ">HKIT</a>) shares rose 16.66% to $1.19. The market value of their outstanding shares is at $17.1 million. </li>
<li>AudioEye (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEYE#NASDAQ">AEYE</a>) shares rose 15.73% to $13.71. The company's market cap stands at $159.8 million. As per the news, the Q1 earnings report came out today. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Tungray Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRSG#NASDAQ">TRSG</a>) shares declined by 27.5% to $5.37 during Tuesday's regular session. The market value of their outstanding shares is at $24.4 million. </li>
<li>Prairie Operating (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PROP#NASDAQ">PROP</a>) stock decreased by 16.48% to $11.81. The company's market cap stands at $118.4 million. </li>
<li>Kopin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KOPN#NASDAQ">KOPN</a>) stock fell 15.39% to $1.09. The company's market cap stands at $129.2 million. </li>
<li>ARB IOT Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARBB#NASDAQ">ARBB</a>) stock decreased by 14.73% to $1.1. The market value of their outstanding shares is at $29.0 million. </li>
<li>Strong Global (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SGE#AMEX">SGE</a>) shares decreased by 13.8% to $1.2. The market value of their outstanding shares is at $9.4 million. </li>
<li>Nano Labs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NA#NASDAQ">NA</a>) shares fell 11.34% to $0.4. The market value of their outstanding shares is at $16.5 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AEYE

ARBB

BTCM

HKIT

KOPN

NTRP

PROP

TRSG

12 Information Technology Stocks Moving In Tuesday's Intraday Session

According to a new report, German media company Axel Springer is considering an acquisition of The Wall Street Journal, expanding its already significant presence in the United States. The company currently owns Insider, Politico, <a href="http://benzinga.com/m-a/21/08/22680278/axel-springer-acquires-politico-in-reported-1b-deal">and other media assets.</a>
What Happened: Axel Springer CEO Mathias Döpfner has plans to grow the publisher in the United States, which comes at a time when media companies are deciding the role artificial intelligence could play in the <a href="https://www.benzinga.com/markets/equities/23/12/36226257/openai-global-publisher-axel-springer-collaborate-to-train-genai-for-journalism-content-creation">future of journalism</a>.
A report from <a href="https://www.semafor.com/article/04/21/2024/axel-springers-trump-years">Semafor </a>links Axel Springer to interest in acquiring The Wall Street Journal.
Axel Springer recently opened a new headquarters in the United States, which could be a sign of its growing ambitions in the country. A 2023 Economist <a href="https://www.economist.com/business/2023/02/23/axel-springer-is-going-all-in-on-america">report </a>also pointed to the media company looking to increase its presence in the United States.
The company could also be looking to spin off assets in Europe, moves that would come as it boosts its U.S. presence, and also to bring a return on investment to KKR &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>), which is the largest shareholder in the company.
Döpfner is also a key owner of around 22% of the company.
Reports of a larger U.S. presence comes as one of the company's key American assets (Insider)<a href="https://www.benzinga.com/news/24/01/36572896/bill-ackman-axel-springer-controversy-brews-business-insider-faces-editorial-review-over-accusations"> is in conflict </a>with leading American investor Bill Ackman.
According to the report, Döpfner pushed to fire Nicholas Carlson, a Business Insider editor, over his coverage of Ackman's wife Neri Oxman.
The report indicates that while Axel Springer has publicly defended its coverage of Ackman's wife, private discussions indicate the company is considering some of Ackman's demands. The conversation centers on whether meeting Ackman&#8217;s conditions could circumvent a costly legal battle, with Ackman represented by the defamation law firm Clare Locke.
As the company pursues acquisitions in the U.S., the Ackman issue has the potential to divert significant time and financial resources, potentially impeding the company&#8217;s growth in America until the case is resolved.
Related Link: <a href="https://www.benzinga.com/news/24/01/36634863/business-insider-is-toast-bill-ackman-vows-to-unleash-hell-in-lawsuit-against-media-site-over-plagia">&#8216;Business Insider Is Toast:&#8217; Bill Ackman Vows To &#8216;Unleash Hell&#8217; In Lawsuit Against Media Site Over Plagiarism Claims Against Wife</a>
Why It's Important: The report on Axel Springer also hits on the company's relationship with people close to former President Donald Trump in years past.
Axel Springer worked to maintain a relationship with the Trump administration during his time in the White House.
The media company prides itself in trying to be neutral in politics coverage. A 2022 Washington Post <a href="https://www.washingtonpost.com/media/2022/09/06/mathias-dopfner-trump-email-axel-springer-politico/">story </a>that showed leaked emails in which Döpfner appeared to express support for the re-election of Trump, seemingly contradicting this stance. Döpfner later said he was being sarcastic.
"All media executives, including Mathias, take meetings and have professional relationships with business leaders, political figures and government officials who hold a wide array of political views – it's part of the job," an Axel Springer spokesperson told Semafor.
Axel Springer also has had a strong relationship with Richard Grenell in the past. Grenell is the former U.S. Ambassador to Germany and considered a potential Secretary of State candidate if Trump is re-elected.
With its past relationships with the Trump administration and potential expansion through further U.S. media acquisitions, Axel Springer may increasingly influence the landscape of American political coverage.
Read Next: <a href="https://www.benzinga.com/news/24/02/37393818/google-faces-2-3b-lawsuit-from-european-media-over-ad-practices">Google Faces $2.3B Lawsuit from European Media Over Ad Practices</a>
Photo: Shutterstock

Politics

Insider, Politico Owner Could Have Eyes On Wall Street Journal Next: Why Battle With Bill Ackman Is Far From Over

Citigroup analyst Jon Tower maintains Yum Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YUM#NYSE">YUM</a>) with a Buy and lowers the price target from $166 to $162.

Citigroup Maintains Buy on Yum Brands, Lowers Price Target to $162

National Bank Financial Inc analyst Ahmed Abdullah maintains AirBoss of America (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ABSSF#OTC">ABSSF</a>) with a Sector Perform and raises the price target from $6 to $6.25.

ABSSF

National Bank Financial Inc Maintains Sector Perform on AirBoss of America, Raises Price Target to $6.25

<a href="https://www.econclubny.org/web/pages/events" title="https://www.econclubny.org/web/pages/events">https://www.econclubny.org/web/pages/events</a>

Events

JPMorgan CEO Says Government Would Be Better Off With 'Practitioners' At Table

Wedbush analyst Robert Driscoll reiterates Adicet Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACET#NASDAQ">ACET</a>) with a Outperform and maintains $5 price target.

ACET

Wedbush Reiterates Outperform on Adicet Bio, Maintains $5 Price Target

Citigroup analyst Steven Enders maintains Workiva (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WK#NYSE">WK</a>) with a Buy and lowers the price target from $110 to $95.

Citigroup Maintains Buy on Workiva, Lowers Price Target to $95

HC Wainwright &amp; Co. analyst Mitchell Kapoor maintains Cartesian Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAC#NASDAQ">RNAC</a>) with a Buy, adjusts target to $54 from $2.

RNAC

HC Wainwright & Co. Maintains Buy on Cartesian Therapeutics, Adjusts Price Target To $54

Citigroup analyst Steven Enders maintains Vertex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERX#NASDAQ">VERX</a>) with a Neutral and lowers the price target from $34 to $32.

VERX

Citigroup Maintains Neutral on Vertex, Lowers Price Target to $32

<a href="https://www.econclubny.org/web/pages/events">https://www.econclubny.org/web/pages/events</a>
&nbsp;

JPMorgan CEO Jamie Dimon Speaks At Economic Club Of New York Event Says Geopolitical Situation Is Most Complicated And Dangerous Since World War II; Our Relationship With China Is Very Complicated; There's A Chance Stagflation Could Happen Again; U.S. Economy Is 'Unbelievable' And Booming

Morgan Stanley analyst Ricky Goldwasser maintains Doximity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOCS#NYSE">DOCS</a>) with a Underweight and maintains $25 price target.

DOCS

Morgan Stanley Maintains Underweight on Doximity, Maintains $25 Price Target

Citigroup analyst Steven Enders maintains Intapp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTA#NASDAQ">INTA</a>) with a Buy and lowers the price target from $57 to $52.

INTA

Citigroup Maintains Buy on Intapp, Lowers Price Target to $52

World-Leading Hydrogen Supplier's Latest Commitment Further Supports Canada's&nbsp; Climate and Energy Goals and 5,000 Hydrogen Vehicle Challenge

Air Products Plans To Build Network Of Commercial-Scale Multi-Modal Hydrogen Refueling Stations Connecting Edmonton And Calgary, Alberta, Canada

Longleaf Partners International Fund Q4 2023 Commentary

Alibaba Stock: Undervalued With Substantial Risks

NetEase, Tencent jump after China regulator removes gaming rules draft from website

Naspers: Prosus Not Fully Recognised, Venture Assets Negatively Valued

Prosus: The Underperformance Continues

Prosus N.V. To Rise On Strong Growth And Deep Low Valuation

In a report released today, Marcus Diebel from J.P. Morgan maintained a Buy rating on Prosus (PROSF – Research Report), with a price target of €48....

J.P. Morgan Reaffirms Their Buy Rating on Prosus (PROSF)

Prosus: A Great Long-Term Play, With Clear Short-Term Upside Potential

In a report released today, Marcus Diebel from J.P. Morgan maintained a Buy rating on Prosus (PROSF – Research Report), with a price target of €46....